Market Tracker

04/22 4:45pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

61.99
Data as of Apr 22
 +0.65 / +1.06%
Today’s Change
53.53
Today|||52-Week Range
84.25
-11.88%
Year-to-Date

Today’s Trading

Previous close61.34
Today’s open62.84
Day’s range61.81 - 63.42
Volume2,592,343
Average volume (3 months)1,650,813
Market cap$8.7B
Dividend yield--
Data as of 3:59pm ET, 04/22/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)-40.50%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book6.51

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+1.67+2.79%
JAZZJazz Pharmaceuticals...+7.02+5.07%
INCYIncyte Corp+1.87+3.94%
RDYDr.Reddy's Laborator...+0.36+0.85%
Data as of 4:01pm ET, 04/22/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts